# Royal Bank of Canada

Type: Company

Source: GetYourBrief — https://getyourbrief.com/entity/royal-bank-of-canada
Canonical HTML page: https://getyourbrief.com/entity/royal-bank-of-canada

## Timeline

- **2026-08-23**: Wall Street Zen upgrades both stocks to Hold — Wall Street Zen upgraded CTNM and ENVB from Sell to Hold in Sunday research notes.
- **2026-08-16**: NBRHC Foundation recognizes $60,000 grant — North Bay Regional Health Centre Foundation announces RBC Foundation's $60,000 grant to improve accessibility at Mishkikiwan.
- **2026-08-14**: Enveric reports quarterly loss — Enveric Biosciences reported EPS of -$0.76 for the quarter.
- **2026-08-05**: Q2 2026 earnings release for Lineage and Magnite — Both companies reported earnings after market close: Lineage EPS $0.76 (beat by $0.98), Magnite EPS $0.26 (beat by $0.01).
- **2026-07-31**: RBC raises CTNM target to $23 — Royal Bank of Canada raised its Contineum target from $22.00 to $23.00 with an Outperform rating.
- **2026-07-30**: Contineum reports Q2 results — Contineum reported Q2 EPS of -$0.40, beating consensus by $0.05.
- **2026-07-21**: Lineage dividend payment date — Lineage paid quarterly dividend of $0.5325 to shareholders of record on June 30.
- **2026-07-17**: Wells Fargo raises Magnite target — Wells Fargo increased price objective from $15 to $21, maintained Equal Weight.
- **2026-07-17**: Weiss Ratings reiterates Sell ratings — Weiss Ratings restated a Sell (d-) on CTNM and a Sell (e+) on ENVB.
- **2026-07-10**: GrafTech shares trade 2.6% higher — Shares rose to $5.9110 on below-average volume of 206,136 shares, after a prior close of $5.76.
- **2026-Q3 (estimated)**: Clinical Catalyst — Anticipated data readouts for sevasemten in Becker Muscular Dystrophy trials.
- **2026-06-30**: Lineage dividend record date — Record date for Lineage's quarterly dividend of $0.5325 per share.
- **2026-06-29**: Weiss Ratings lowers to sell (e+) — Weiss Ratings lowered GrafTech from sell (d-) to sell (e+).
- **2026-06-11**: Three directors execute insider purchases — Philip Fracassa buys 5,000 MBC shares, Paul Koonce buys 500 SR shares, and Frederick Disanto buys 1,000 EML shares, all in open-market transactions.
- **2026-05-28**: RBC reaffirms Magnite Outperform — Royal Bank of Canada reiterated an Outperform rating on Magnite shares.

## Recent coverage (20 stories, network-wide)

### Hold Upgrades for CTNM and ENVB: $20.25 Target vs $1.43 Microcap
2026-08-24 11:32:31 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

A Sunday analyst action shifted two healthcare microcaps from Sell to Hold. CTNM carries a $646.69M valuation and a $20.25 consensus target, while ENVB trades at $1.43 with a $6.41M market cap and negative P/E.
Full story: https://getfinancebrief.com/story/wall-street-zen-ctnm-envb-hold-upgrades-finance

### Wall Street Zen Upgrades 2 Biotechs: CTNM at $17.19, ENVB at $1.43
2026-08-24 11:32:21 · Sector: bio · Sentiment: Neutral · Impact: 5/10 · Sources: 2

A rare double upgrade by Wall Street Zen moved Contineum Therapeutics and Enveric Biosciences from Sell to Hold, offering a momentary reprieve for two money-losing clinical-stage biotechs. CTNM trades near its 52-week high at $17.19 with a $20.25 consensus target, while ENVB's psychedelic pipeline carries a $6.41M market cap against a former $17.64 high.
Full story: https://getbiobrief.com/story/wall-street-zen-upgrades-two-biotechs-ctnm-envb-hold-bio

### Orion180's $80.1M H1 Revenue Powers Nasdaq IPO Filing
2026-08-21 16:10:53 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Melbourne, Florida-based Orion180 filed for a Nasdaq IPO under OIG after swinging to $13.5 million net income on $80.1 million revenue in H1 2026. The E&S homeowners insurer reports $601 million in direct written premiums and over 14,000 agents. Underwriters include Goldman Sachs, RBC, and UBS.
Full story: https://getfinancebrief.com/story/orion180-ipo-nasdaq-oig-finance

### RTX Up 1.1% With $250 High Target; GEV Gains 1.3% as Analysts See $1,338
2026-08-17 03:06:46 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Analysts remain mostly bullish on RTX and GE Vernova after July earnings, lifting price targets to as high as $250 and $1,338 respectively. Friday's gains came on unusually light volume, raising questions about conviction. Finance readers get a breakdown of target upside, valuation, and risk metrics.
Full story: https://getfinancebrief.com/story/rtx-gev-analyst-targets-low-volume-gains

### RBC's $60K Grant Expands Indigenous Healing Space Access at NBRHC
2026-08-17 00:52:33 · Sector: health · Sentiment: Neutral · Impact: 5/10 · Sources: 3

RBC Foundation's $60,000 Community Spaces Grant will fund wheelchair and stretcher access to Mishkikiwan, North Bay Regional Health Centre's outdoor ceremonial grounds, strengthening culturally safe Indigenous care.
Full story: https://gethealthbrief.com/story/rbc-60k-grant-nbrhc-indigenous-healing-access

### RBC Foundation Deploys $60K Grant in Ontario Hospital Community Space
2026-08-17 00:52:23 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 3

RBC Foundation's $60,000 grant to North Bay Regional Health Centre is a small but strategic community investment under its Canadian ESG and reconciliation commitments, reinforcing brand equity in Northern Ontario.
Full story: https://getfinancebrief.com/story/rbc-foundation-60k-community-spaces-grant-nbrhc

### Morgan Stanley Cuts AMH PT to $38, Sees 11% Upside in SFR
2026-08-16 15:04:23 · Sector: proptech · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Single-family rental REIT American Homes 4 Rent has a modestly reduced $38 price target from Morgan Stanley, still above a $36.78 consensus and leaving 11% upside. The maintained Overweight rating reinforces the resilience of the SFR asset class amid housing supply constraints.
Full story: https://getproptechbrief.com/story/morgan-stanley-amh-38-proptech-sfr

### Morgan Stanley Cuts AMH PT to $38; Consensus $36.78, 11% Upside
2026-08-16 15:04:14 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Morgan Stanley trimmed its American Homes 4 Rent target to $38 from $38.50 while keeping an Overweight rating, against a $36.78 consensus and Moderate Buy average. Equity research actions from Jefferies, UBS, RBC, Mizuho, and Compass Point reveal a broadly constructive but price-sensitive stance on the REIT.
Full story: https://getfinancebrief.com/story/morgan-stanley-amh-price-target-38-finance

### Graphite Electrode Maker EAF Jumps 2.6% to $5.91 Amid Supply Chain Headwinds
2026-08-12 17:11:16 · Sector: supply · Sentiment: Neutral · Impact: 5/10 · Sources: 2

GrafTech's 2.6% daily rise obscures deeper weakness: analyst downgrades, an EPS miss of $0.80, and a market cap of just $154M. For supply chain professionals, the move is a reminder to watch graphite electrode pricing and supplier financial health.
Full story: https://getsupplybrief.com/story/graftech-eaf-supply-chain-2-6-percent-rise-july-2026

### Camping World Upgraded from Sell to Hold: 95% Upside to $12 Target
2026-08-11 09:53:05 · Sector: retail · Sentiment: Neutral · Impact: 5/10 · Sources: 3

Camping World (CWH) saw a rare sell-to-hold upgrade from Wall Street Zen, with analysts maintaining a consensus price target of $12.02—95% above the $6.16 stock price. For retail investors, the call may signal a bottom in RV demand despite a recent revenue miss.
Full story: https://getretailbrief.com/story/camping-world-upgrade-retail-consumer

### ZipRecruiter Upgraded: 32% Rally Above 50-Day MA, Insider Sells $33K
2026-08-11 09:52:53 · Sector: hr · Sentiment: Neutral · Impact: 5/10 · Sources: 3

Wall Street Zen upgraded ZipRecruiter from hold to buy, driving the stock 32% above its 50-day moving average to $5.05. Despite the bullish call, overall analyst consensus remains Reduce, and an EVP sold $33,000 in shares, highlighting mixed signals for HR tech.
Full story: https://gethrbrief.com/story/ziprecruiter-upgrade-insider-sell-hr-tech

### Wall Street Zen Sparks 5 Upgrades Across $81.8B in Market Cap
2026-08-11 09:52:23 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 3

On August 8, 2026, Wall Street Zen simultaneously upgraded five stocks from energy to retail, moving a combined market cap of $81.8 billion. The moves highlight a potential shift in analyst sentiment and sector rotation as Q2 earnings season winds down.
Full story: https://getfinancebrief.com/story/wall-street-zen-upgrades-wave

### Lineage EPS Beats by $0.98, but Cold Storage Revenue Growth Stalls to 0.8%
2026-08-09 13:39:35 · Sector: supply · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Lineage, a leading cold storage REIT, reported a massive EPS beat but negligible revenue growth, highlighting softness in food logistics demand. The negative dividend payout ratio raises sustainability questions for income-focused investors.
Full story: https://getsupplybrief.com/story/lineage-earnings-beat-supply-chain

### Magnite Revenue Hits $192.8M (+11.3%), Beats by $0.01 EPS on CTV Strength
2026-08-09 13:39:27 · Sector: marketing · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Magnite's Q2 adtech earnings surpassed estimates, driven by 11.3% revenue growth, robust net margins of 21.96%, and a strong analyst consensus. The stock dip belies underlying platform health and CTV momentum.
Full story: https://getmarketingbrief.com/story/magnite-earnings-beat-adtech

### Earnings Face-Off: Lineage $0.98 Beat vs Magnite $0.01 Beat—Which Stock Wins?
2026-08-09 13:39:19 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Two disparate earnings beats: Lineage posted a massive $0.98 EPS surprise but carries negative margins, while Magnite delivered a smaller beat with solid profitability. The comparison reveals risks in chasing headline beats and highlights valuation disconnects.
Full story: https://getfinancebrief.com/story/lineage-magnite-earnings-comparison

### Agenus Upgraded to Buy After 189% Surge Off 12M Low: Analysts Eye $30 Target
2026-08-08 12:53:05 · Sector: bio · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Wall Street Zen upgraded biotech Agenus to buy despite a massive Q1 earnings miss, as the stock surged 189% from its 52-week low. Mixed analyst views and a $30 HC Wainwright target highlight the speculative upside in immuno-oncology.
Full story: https://getbiobrief.com/story/agenus-upgraded-buy-189-percent-surge

### CPKC's $2.93B quarterly revenue signals 12.6% growth for North American freight
2026-08-03 17:03:01 · Sector: supply · Sentiment: Neutral · Impact: 6/10 · Sources: 2

CPKC's Q2 earnings beat, with revenue up 12.6% to $2.93 billion, highlights robust cross-border rail demand. For supply chain professionals, the performance reflects strong trade flows and network integration benefits post-merger.
Full story: https://getsupplybrief.com/story/cpkc-q2-2026-supply-chain-impact

### CPKC beats Q2 estimates with $0.92 EPS; analysts see 16% upside to $105
2026-08-03 17:02:51 · Sector: finance · Sentiment: Neutral · Impact: 6/10 · Sources: 2

Canadian Pacific Kansas City posted a $0.03 EPS beat and 12.6% revenue growth, maintaining strong margins. With a consensus Buy rating and price targets as high as $105, the stock offers a defensive growth story for investors.
Full story: https://getfinancebrief.com/story/cpkc-q2-2026-earnings-beat-finance

### Sun Communities' FY26 EPS Guidance Tops $6.93 Consensus With $7.10 High-End
2026-07-28 01:45:35 · Sector: proptech · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Sun Communities’ FY 2026 EPS guidance of $6.94–$7.10, surpassing consensus, signals resilience in manufactured housing REITs. The update, alongside a massive Q2 loss, highlights the need for operational technology to improve asset performance and expense control.
Full story: https://getproptechbrief.com/story/sun-communities-fy26-guidance-proptech-implications

### Sun Communities Guides FY26 EPS to $7.10 High-End, 15% Below Avg Analyst Target
2026-07-28 01:45:22 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Sun Communities’ FY 2026 EPS guidance of $6.94–$7.10 beat the $6.93 consensus, but shares fell 0.4% on heavy volume as revenue guidance was absent. Analyst targets average $140.05, suggesting 15% upside from $121.30 despite recent price target cuts.
Full story: https://getfinancebrief.com/story/sun-communities-fy26-guidance-finance-market-impact

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.